SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-031606
Filing Date
2023-06-27
Accepted
2023-06-27 08:30:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20009606x1_defa14a.htm DEFA14A 10049
2 ny20009606x1_graphic1.jpg GRAPHIC 89580
3 ny20009606x1_graphic2.jpg GRAPHIC 120795
  Complete submission text file 0001140361-23-031606.txt   301325
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-31141 | Film No.: 231044037
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences